FMP
NASDAQ
1.1 USD
-0.005 (-0.45%)
Dr. Iraj Ali Ph.D.
Healthcare
Biotechnology
https://www.achillestx.com
NASDAQ
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therap...
0001830749
US00449L1026
00449L102
245 Hammersmith Road
44 20 8154 4600
GB
234
Mar 31, 2021
0001830749
NASDAQ
Biotechnology
Healthcare
00449L102
US00449L1026
GB
1.1
1.09
760.66k
44.86M
-
0.74-1.76
4.21
-
-
-
-
-0.58
-
https://www.achillestx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.